Oncopeptides AB (publ) (STO:ONCO)

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceutical Drugs	35.22M	Log In	Log In
Pharmaceutical Drugs Growth	321.54%	Log In	Log In

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	24.33M	Log In	Log In
United States Growth	212.12%	Log In	Log In
Europe	10.89M	Log In	Log In
Germany	-	Log In	Log In